Interestingly, Campbell et al. [47] previously reported a low number of truncated mutations in proofreading domain as compared to the region outside of proofreading domain, and one-third of truncated POLE and POLD1 mutations did not cause high tumor mutation burden. The gene discussed is POLD1; the disease is neoplasm.